Bulgaria - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingBulgaria: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022
Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Bulgaria
In 2021, the Bulgarian human and animal blood market was finally on the rise to reach $X after two years of decline. Overall, consumption posted significant growth. Human and animal blood consumption peaked in 2021 and is expected to retain growth in years to come.
Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Bulgaria
In value terms, human and animal blood production rose significantly to $X in 2021 estimated in export price. Over the period under review, production showed a resilient increase. The pace of growth appeared the most rapid in 2018 when the production volume increased by X%. Over the period under review, production reached the peak level at $X in 2019; however, from 2020 to 2021, production failed to regain momentum.
Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses
Exports from Bulgaria
In 2021, the amount of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses exported from Bulgaria soared to X tons, growing by X% on 2020 figures. Over the period under review, total exports indicated a noticeable expansion from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports decreased by -X% against 2019 indices. Over the period under review, the exports reached the maximum at X tons in 2019; however, from 2020 to 2021, the exports remained at a lower figure.
In value terms, human and animal blood exports declined modestly to $X in 2021. The total export value increased at an average annual rate of +X% from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2017 with an increase of X%. The exports peaked at $X in 2018; however, from 2019 to 2021, the exports stood at a somewhat lower figure.
Exports by Country
The United States (X tons), Russia (X tons) and Lithuania (X tons) were the main destinations of human and animal blood exports from Bulgaria, with a combined X% share of total exports.
From 2012 to 2021, the biggest increases were in Lithuania (with a CAGR of +X%), while shipments for the other leaders experienced more modest paces of growth.
In value terms, the United States ($X) remains the key foreign market for human and animal blood exports from Bulgaria, comprising X% of total exports. The second position in the ranking was held by Russia ($X), with a X% share of total exports. It was followed by North Macedonia, with a X% share.
From 2012 to 2021, the average annual rate of growth in terms of value to the United States amounted to +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Russia (-X% per year) and North Macedonia (+X% per year).
Export Prices by Country
In 2021, the average human and animal blood export price amounted to $X per ton, dropping by -X% against the previous year. In general, the export price showed a relatively flat trend pattern. The pace of growth was the most pronounced in 2020 an increase of X%. As a result, the export price reached the peak level of $X per ton, and then contracted rapidly in the following year.
Prices varied noticeably by the country of destination: the country with the highest price was North Macedonia ($X per ton), while the average price for exports to Lithuania ($X per ton) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to the United States (-X%), while the prices for the other major destinations experienced a decline.
Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses
Imports into Bulgaria
In 2021, overseas purchases of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were finally on the rise to reach X tons after two years of decline. Overall, imports showed a significant increase. As a result, imports reached the peak and are likely to continue growth in the immediate term.
In value terms, human and animal blood imports skyrocketed to $X in 2021. Over the period under review, imports continue to indicate a buoyant expansion. The most prominent rate of growth was recorded in 2016 with an increase of X% against the previous year. Imports peaked in 2021 and are likely to continue growth in the near future.
Imports by Country
In 2021, Ukraine (X tons) constituted the largest supplier of human and animal blood to Bulgaria, accounting for a X% share of total imports. Moreover, human and animal blood imports from Ukraine exceeded the figures recorded by the second-largest supplier, Germany (X tons), threefold. The third position in this ranking was taken by Latvia (X tons), with a X% share.
From 2012 to 2021, the average annual growth rate of volume from Ukraine totaled +X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (+X% per year) and Latvia (+X% per year).
In value terms, the largest human and animal blood suppliers to Bulgaria were Poland ($X), Ukraine ($X) and Austria ($X), with a combined X% share of total imports.
In terms of the main suppliers, Ukraine, with a CAGR of +X%, recorded the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
In 2021, the average human and animal blood import price amounted to $X per ton, declining by -X% against the previous year. In general, the import price showed a abrupt curtailment. The pace of growth appeared the most rapid in 2014 an increase of X%. As a result, import price reached the peak level of $X per ton. From 2015 to 2021, the average import prices remained at a lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Poland ($X per ton), while the price for Ukraine ($X per ton) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Ukraine (+X%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the market for human and animal blood in Bulgaria. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)
Country coverage:
- Bulgaria
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Bulgaria
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the global market for human and animal blood.
This report provides an in-depth analysis of the market for human and animal blood in the EU.
This report provides an in-depth analysis of the market for human and animal blood in Asia.
This report provides an in-depth analysis of the market for human and animal blood in the U.S..
This report provides an in-depth analysis of the market for human and animal blood in China.
- Market Research in Bulgaria
- Human and Animal Blood Market
- Polymer Ion-exchangers Market
- Phenolphthalein and Lactones Market
- Hydantoin Market
- Malonylurea and Its Derivatives Market
- Compounds Containing A Pyrimidine Ring Market
- Compounds Containing An Unfused Triazine Ring Market
- Compounds Containing A Phenothiazine Ring-system Market
- Sulphonamides Market